The Marcus(MCS)
Search documents
Marcus (MCS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2024-10-24 15:06
Wall Street expects a year-over-year increase in earnings on higher revenues when Marcus (MCS) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 31. On ...
Should Value Investors Buy The Marcus (MCS) Stock?
ZACKS· 2024-10-18 14:45
Core Insights - The Marcus Corporation (MCS) is highlighted as a strong value stock with a Zacks Rank of 2 (Buy) and a Value grade of A [1][2] - Value investing is emphasized as a popular strategy, focusing on fundamental analysis and traditional valuation metrics to identify undervalued stocks [1] Valuation Metrics - MCS has a Price-to-Sales (P/S) ratio of 0.76, significantly lower than the industry average P/S of 1.21, indicating potential undervaluation [2] - The Price-to-Cash Flow (P/CF) ratio for MCS is 10.64, compared to the industry average of 16.75, suggesting a solid cash outlook [2] - Over the past 12 months, MCS's P/CF has fluctuated between a high of 10.72 and a low of 3.93, with a median of 7.09, further supporting the notion of undervaluation [2]
Recent Price Trend in Marcus (MCS) is Your Friend, Here's Why
ZACKS· 2024-10-18 13:50
Core Viewpoint - The article emphasizes the importance of timing and sustainability in stock trends for successful short-term investing, highlighting the need for strong fundamentals and positive earnings estimates to maintain momentum [1]. Group 1: Stock Performance - Marcus (MCS) has shown a solid price increase of 34.6% over the past 12 weeks, indicating investor confidence in its potential upside [2]. - The stock has also increased by 9.3% over the last four weeks, suggesting that the upward trend is still intact [2]. - MCS is currently trading at 98.7% of its 52-week high-low range, indicating a potential breakout [2]. Group 2: Fundamental Strength - MCS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [3]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [3]. Group 3: Investment Strategy - The article suggests that MCS may continue its price trend without reversal in the near future, and encourages exploring other stocks that meet similar criteria [4]. - It highlights the availability of over 45 Zacks Premium Screens designed to identify potential winning stocks based on various investing styles [4].
Despite Fast-paced Momentum, Marcus (MCS) Is Still a Bargain Stock
ZACKS· 2024-10-08 13:50
Core Viewpoint - Momentum investing focuses on "buying high and selling higher" rather than traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investors often face challenges in determining the right entry point, as stocks may lose momentum when their valuations exceed future growth potential [2] - Investing in bargain stocks that exhibit recent price momentum can be a safer strategy, utilizing tools like the Zacks Momentum Style Score to identify promising stocks [3] Group 2: Case Study - Marcus (MCS) - Marcus (MCS) has shown significant price momentum, with a four-week price change of 7.4%, indicating growing investor interest [4] - Over the past 12 weeks, MCS stock has gained 38.5%, with a beta of 1.52, suggesting it moves 52% more than the market [5] - MCS has a Momentum Score of B, indicating a favorable time to invest, and it has a Zacks Rank 2 (Buy) due to upward revisions in earnings estimates [6][7] - The stock is currently trading at a Price-to-Sales ratio of 0.73, suggesting it is undervalued at 73 cents for each dollar of sales [7] Group 3: Additional Opportunities - Besides MCS, there are other stocks that meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, presenting further investment opportunities [8] - Investors can explore over 45 Zacks Premium Screens tailored to different investing styles to identify potential winning stocks [9]
Marcus Stock Hits 52-Week High: Should You Wait for a Dip or Buy Now?
ZACKS· 2024-10-03 16:21
Shares of The Marcus Corporation (MCS) touched a new 52-week high of $16.17 on Wednesday. The stock pulled back to end the trading session at $16.09. The company's shares have surged 44% in the past three months, outpacing the industry's gain of 11.1%. The stock has also outperformed the S&P 500 and the Consumer Discretionary sector's increase of 2.6% and 7.6%, respectively. In the same time frame, other stocks like AMC Entertainment Holdings, Inc. (AMC) , Target Hospitality Corp. (TH) and Six Flags Enterta ...
Marcus (MCS) Stock Surges 5.02% with Strong Trading Volume
GuruFocus· 2024-10-02 20:14
Marcus (MCS, Financial) experienced a notable stock price increase of 5.02%, currently trading at $15.91 per share. The trading volume reached 249,467 shares, with a turnover rate of 0.78% and a volatility of 4.75%. Recent financial reports for Marcus indicate a revenue of $176 million, a net income loss of $20.22 million, and an earnings per share (EPS) of -$0.63. The price-to-earnings (P/E) ratio stands at -22.64. Presently, no institutions have issued buy, hold, or sell ratings for Marcus. In the enterta ...
Wall Street Analysts Think Marcus (MCS) Could Surge 27.59%: Read This Before Placing a Bet
ZACKS· 2024-10-02 14:56
Shares of Marcus (MCS) have gained 7.5% over the past four weeks to close the last trading session at $15.15, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $19.33 indicates a potential upside of 27.6%. The average comprises three short-term price targets ranging from a low of $18 to a high of $20, with a standard deviation of $1.15. While the lowest estimate indicates an incre ...
Marcus (MCS) is on the Move, Here's Why the Trend Could be Sustainable
ZACKS· 2024-10-02 13:50
Most of us have heard the dictum "the trend is your friend." And this is undeniably the key to success when it comes to short-term investing or trading. But it isn't easy to ensure the sustainability of a trend and profit from it. The trend often reverses before exiting the trade, leading to a short-term capital loss for investors. So, for a profitable trade, one should confirm factors such as sound fundamentals, positive earnings estimate revisions, etc. that could keep the momentum in the stock alive. Our ...
Alexandria Real Estate Equities, Inc. Executive Chairman and Founder Joel S. Marcus to Be Honored With the Inaugural Bisnow Life Sciences Icon & Influencer Award
Prnewswire· 2024-09-10 12:30
Core Insights - Alexandria Real Estate Equities, Inc. is being recognized for its significant contributions to the life science real estate sector, with its executive chairman, Joel S. Marcus, receiving the inaugural Bisnow Life Sciences Icon & Influencer Award [1][2] - The company has transformed life science real estate into a mainstream asset class, with its tenants responsible for 50% of the approximately 500 novel FDA-approved therapies since 2013 [2] Company Overview - Alexandria Real Estate Equities, Inc. was co-founded in 1994 and is a leading owner, operator, and developer of collaborative mega campuses in key life science innovation locations [2][4] - As of June 30, 2024, the company has a market capitalization of $32.5 billion and an asset base that includes 42.1 million RSF of operating properties and 5.3 million RSF of Class A/A+ properties under construction [4] - The company focuses on creating dynamic environments that enhance tenant productivity and success, while also providing strategic capital to transformative life science companies [4][5] Industry Impact - Alexandria plays a pivotal role in creating life science ecosystems that foster innovation in new medicines, addressing the significant unmet medical needs with over 90% of known diseases lacking approved therapies [3] - The company is positioned at the forefront of the life science industry, which is a vital $5 trillion sector, and continues to drive growth through its Labspace® platform [3]
Haivision MCS Awarded $61.2 Million Production Agreement by US Navy for Next-Generation Combat Visualization and Video Distribution Systems
Prnewswire· 2024-09-03 12:30
MONTREAL, Sept. 3, 2024 /PRNewswire/ - Haivision Systems Inc. ("Haivision") (TSX: HAI), a leading global provider of mission-critical, real-time video streaming and networking solutions, today announced that Haivision MCS, a subsidiary of Haivision, was awarded a significant five-year production agreement by the Naval Sea Systems Command (NAVSEA), with an estimated total value of $61.2 million USD (approximately $82 million CAD). This strategic agreement positions Haivision at the forefront of delivering cu ...